HR-Positive Metastatic Breast Cancer — Year in Review Series on Relevant New Datasets and Advances in the PI3K/AKT/mTOR Pathway

Featuring perspectives from Dr Virginia Kaklamani and Dr Hope S Rugo, including the following topics:

• Introduction: San Antonio Memories (0:00)
• PI3K/AKT/PTEN Alterations and Therapies (7:18)
• Capivasertib (20:22)
• Gedatolisib (34:08)
• Inavolisib (47:07)
• New Agents and Ongoing Trials (52:34)

CME information and select publications